Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE.
about
Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approachesToward a therapy for mitochondrial diseaseLiver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathyLong term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances.Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.Emerging therapies for mitochondrial disorders.Mitochondrial diseases: advances and issues.Mutations causing mitochondrial disease: What is new and what challenges remain?Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.Sustained AMPK activation improves muscle function in a mitochondrial myopathy mouse model by promoting muscle fiber regeneration.Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease.Thymidine phosphorylase: A potential new target for treating cardiovascular disease.NEWS and VIEWS: mitochondrial encephalomyopathies.Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE.
P2860
Q26801561-8EFE1FBA-7479-43B6-8F47-E4AD81F41E83Q28080024-708D7B0E-9ACD-4187-BC23-D94FD47B5715Q33573502-991253D4-C85B-4BDA-8AE6-40CE2F084E3BQ34552728-81DBFD81-E1A6-45DA-95F2-9FEC29027A36Q35893619-342DC968-858B-47E2-8711-A5B74AAE107DQ36967723-1A696957-070C-4314-83F3-8687AC9E5C16Q37653002-37C377F8-62FA-4858-9B2D-232399F26932Q38592664-FFE430F9-6A2E-4CCC-9490-A3CB8E3D7783Q38750535-6011E941-53B3-476F-B509-E635751AE1FEQ39732168-2880CF78-E967-44C6-8B95-BE2F527AC97BQ40838303-B86C6E5D-9FFF-42BB-9BFB-FC591F8AB349Q40886181-81F322D1-1C1C-4F2C-8AE2-6C7FA73B6C5EQ45305297-596A9C88-53EF-4069-87D8-9B0DF2E2448DQ46210790-134737F1-4946-4798-AB24-48C6F1E4CDEFQ52568126-EE7B3F8C-DAEC-4867-99D3-B208836C1F90
P2860
Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@en
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@nl
type
label
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@en
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@nl
prefLabel
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@en
Gene therapy using a liver-tar ...... is in a murine model of MNGIE.
@nl
P2093
P2860
P50
P356
P1433
P1476
Gene therapy using a liver-tar ...... sis in a murine model of MNGIE
@en
P2093
Carlo Viscomi
Giuseppe Pizzorno
Javier Torres-Torronteras
Massimo Zeviani
Michio Hirano
Raquel Cabrera-Pérez
P2860
P304
P356
10.1038/MT.2014.6
P577
2014-01-22T00:00:00Z